2010 noninvasive si
TRANSCRIPT
-
8/13/2019 2010 Noninvasive SI
1/26
Supporting Information
Wiley-VCH 2010
69451 Weinheim, Germany
Noninvasive Imaging of Dendrimer-Type N-Glycan Clusters: In VivoDynamics Dependence on Oligosaccharide Structure**
Katsunori Tanaka,* Eric R. O. Siwu, Kaori Minami, Koki Hasegawa, Satoshi Nozaki,
Yousuke Kanayama, Koichi Koyama, Weihsu C. Chen, James C. Paulson, Yasuyoshi Watanabe,
and Koichi Fukase*
anie_201000892_sm_miscellaneous_information.pdf
-
8/13/2019 2010 Noninvasive SI
2/26
1
All commercially available reagents were used without further purification. Dichloromethane were
refluxed over and distilled from CaH2and anhydrous DMF was purchased from Aldrich.1H NMR spectra
were recorded on a JEOL JNM-ECA 500 spectrometer and chemical shifts were represented as !-values
relative to the internal standard TMS. MALDI-TOF-mass spectra were measured on an SHIMADZU
AXIMA-CFR mass spectrometer equipped with a nitrogen laser (!= 337 nm). 1H NMR & mass spectra
and purity of the starting glycans, provided by Otsuka Chemical Co., Ltd., are shown below.
Bis--Neu(2-6)Gal containing N-glycan-Asn (glycan a):1H-NMR (500 MHz, D2O, HOD = !4.65)!
5.03 (s, 1H), 4.97 (d, 1H, J= 9.5 Hz), 4.85 (s, 1H), 4.51 (m, 2H), 4.35 (d, 2H,J= 8 Hz), 4.16 (bs, 1H),
4.09 (bs, 1H), 4.02 (bs, 1H), 2.83 (bd, 1H, J= 17 Hz), 2.77 (dd, 1H,J= 7Hz, 17 Hz), 2.56 (bd, 2H, J=
12Hz ), 1.95-2.07 (multi s, 18H), 1.62 (t, 2H, J= 12Hz). ESI-MS calcd for C88H144N8O64Na (M+Na)+
2359.8, found 2360.0.
-
8/13/2019 2010 Noninvasive SI
3/26
2
Asialo N-glycan-Asn (glycan b):1H-NMR (500 MHz, D2O, HOD = !4.65)!5.02 (s, 1H), 4.9(d, 1H,
J= 9.5 Hz), 4.83 (s, 1H), 4.52 (d, 1H, J= 7.5Hz), 4.49 (d, 2H,J= 8 Hz ), 4.38 (dd, 2H,J= 3Hz, 8 Hz),
4.15 (d, 1H,J= 2 Hz ), 4.10 (s, 1H,J= 3 Hz), 4.02 (s, 1H,J= 3 Hz), 2.83 (dd, 1H,J= 17 Hz), 2.77 (dd,
1H, J = 7Hz, 17 Hz), 1.92-2.02 (multi s, 12H). ESI-MS calcd for C66H110N6O48Na (M+Na)+ 1777.6,
found 1777.6.
Bis--Neu(2-3)Gal containing N-glycan-Asn (glycan c): 1H-NMR (500 MHz, D2O, HOD = !4.65)!
4.85 (s, 1H), 4.82 (d, 1H, J= 9.0 Hz), 4.66 (s,1H ), 4.34 (brs, 1H), 4.29 (brs, 2H), 3.98 (s, 1H), 3.93 (s,1H), 3.85 (brs, 2H), 2.68 (dd, 1H, J= 17 Hz), 2.65 (dd, 1H, J= 7Hz, 17 Hz), 2.48 (bd, 2H, J= 12Hz ),
1.70-1.86 (multi s, 12H), 1.53 (t, 2H, J= 18Hz). ESI-MS calcd for C88H144N8O64Na (M+Na)+2359.8,
found 2359.9.
-
8/13/2019 2010 Noninvasive SI
4/26
3
Mixed -Neu(2-3)Gal & -Neu(2-6)Gal containing N-glycan-Asn (glycan d):1H-NMR (500 MHz,
D2O, HOD = !4.65)!4.98 (s, 1H), 4.92 (d, 1H,J= 9.5 Hz), 4.77 (s, 1H), 4.40 (m, 1H), 4.39 (d, 1H,J=
8 Hz), 4.28 (d, 1H,J= 8 Hz), 4.10 (s, 1H), 4.04 (s, 1H), 3.97 (brs, 1H), 2.78 (dd, 1H,J= 17 Hz), 2.71 (dd,
1H,J= 7Hz, 17 Hz), 2.60 (dd, 1H, J= 4.5 Hz, 12.5 Hz ), 2.51 (dd, 1H,J= 4.5 Hz, 12.5 Hz ), 1.85-1.95
(multi s, 18H), 1.64 (t, 2H, J = 18Hz), 1.56 (t, 2H, J = 18Hz). ESI-MS calcd for C88H144N8O64Na
(M+Na)+2359.8, found 2359.8.
-
8/13/2019 2010 Noninvasive SI
5/26
4
Mixed -Neu(2-6)Gal & -Neu(2-3)Gal containing N-glycan-Asn (glycan e):1H-NMR (500 MHz,
D2O, HOD = !4.65)!5.03 (s, 1H), 4.98 (d, 1H,J= 9.5 Hz), 4.87 (s, 1H), 4.50 (m, 1H), 4.36 (d, 1H,J=
8 Hz), 4.36 (d, 1H,J= 8 Hz), 4.17 (s, 1H), 4.11 (s, 1H), 4.04 (brs, 1H), 2.80 (dd, 1H,J= 4 Hz, 17 Hz),
2.74 (dd, 1H,J= 7Hz, 17 Hz), 2.68 (dd, 1H, J= 4.5 Hz, 12.5 Hz ), 2.59 (dd, 1H, J= 4.5 Hz, 12.5 Hz ),
1.88-2.01 (multi s, 18H), 1.71 (t, 2H, J = 18Hz), 1.64 (t, 2H, J = 18Hz). ESI-MS calcd for
C88H144N8O64Na (M+Na)+2359.8, found 2360.0.
-
8/13/2019 2010 Noninvasive SI
6/26
5
Solid-phase synthesis of acetylene-containing polylysine dendrimer (template for click reaction, 16-
mer). To a suspension of Fmoc-Lys(Boc)-OH (39 mg, 84 mol) and MSNT (25 mg, 84 mol) in dry
CH2Cl2(1.0 mL) was added 1-methylimidazole (6.7 L, 84 mol). After the solution was stirred at room
temperature for 1 h, the mixture was treated with Wang resin (30 mg, 28 mol), and shaken overnight at
room temperature. The resin was washed with CH2Cl2(5 min x 5) and DMF (5 min x 5).
To the Fmoc-Lys-attached resin was added 20% piperidine in DMF (1.0 mL), and the mixture was
shaken for 20 min. After the resin was washed with DMF (5 min x 5), the success of the Fmoc
deprotection was checked by bromophenolblue (BPB) test. In a separated flask, DIPC (13 L, 84 mol)
was added to a solution of Fmoc-Lys(Fmoc)-OH (49 mg, 84 mol) and HOBt (11 mg, 84 mol) in DMF
(1.0 mL) at 0 C. After the solution was stirred for another 30 min, the mixture was treated with the
mono-Lys-attached resin, obtained above. The resulting mixture was shaken for 5 h and the resin was
washed with DMF (3 min x 5). Fmoc deprotection & acylation cycle was further repeated by using Fmoc-
Lys(Fmoc)-OH (82 mg, 140 mol), Fmoc-Lys(Fmoc)-OH (132 mg, 220 mol), Fmoc-Lys(Fmoc)-OH
(263 mg, 450 mol), Fmoc-His(Bn)-OH (391 mg, 840 mol), and finally by Fmoc-Pra-OH (281 mg, 840
mol).
After deprotection of Fmoc group on Fmoc-Pra-attached resin, the resulting resin was treated with
Ac2O (279 L, 3.79 mmol) and pyridine (279 L, 5.30 mmol) in CH2Cl2(300 L) and the mixture was
shaken for 3 h at room temperature. The resin was washed by THF, MeOH, CH2Cl2(each 5 min x 5), and
-
8/13/2019 2010 Noninvasive SI
7/26
6
finally by Et2O (5 min x 3), and then dried in vacuo for 3 h. 78 Mg out of 159 mg of the dendrimer-
attached resin obtained above, was then treated with 2.0 mL of TFA/TES/H2O (31 : 1 : 1) and shaken for
30 min at room temperature. The mixture was filtered, and the filtrate was lipophilized to give acetylene-
containing polylysine dendrimer (16-mer) as a white solid (50 mg). The dendrimer were analyzed by
reverse phase HPLC (see Fig. SI-3,column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O
containing 0.1% TFA (10-100% gradient over 40 min, 1 mL/min); UV detection at 250 nm; retention
time: 13.1 min) and gel-filtration HPLC (see Fig. SI-5, column: TSK-Gel G4000PWXL, 7.8 x 300 mm;
0.1 M NaCl at pH 7.2, 1 mL/min; retention time: 13.5 min). 1H-NMR (500 MHz, D2O, HOD = !4.65,
Fig. SI-1): !8.52-8.70 (16H), 6.99-7.37 (m, 96H), 5.24 (brs, 32H), 3.91-4.17 (m, 32H), 2.71-3.18 (m,
32H), 2.36 (s, 16H), 2.25 (m, 32H) 1.85 (s, 3H x 16, Ac), 1.37-1.70 (m, 32H), 0.90-1.37 (m, 64H).
MALDI-TOF-MS m/zcalcd for C416H515N96O65(M+H)+7899.0, found 7899.0 (Fig. SI-2).
Figure SI-1.1H-NMR of acetylene-containing polylysine dendrimer (16-mer) (500 MHz, D2O).
Figure SI-2. MALDI-TOF-MS of acetylene-containing polylysine (16-mer).
-
8/13/2019 2010 Noninvasive SI
8/26
7
Acetylene-containing polylysine dendrimer (4-mer).1H-NMR (500 MHz, D2O, HOD = !4.65): !8.83
(s, 4H), 7.51 (m, 24H), 5.41 (brs, 2H) 4.76 (brs, 4H), 4.67 (brs, 4H), 4.34 (m, 8H), 3.95 (brs, 4H), 3.29 (m,
12H), 2.57 (brs, 4H), 2.44 (m, 8H), 2.07 (s, 3H x 4, Ac), 2.00 (m, 4H), 1.73 (m, 8H), 1.57 (m, 4H), 1.45
(m, 4H), 1.33 (m, 4H); MALDI-TOF-MS m/zcalcd for C104H131N24O17(M+H)+1989.0, found 1989.0.
Acetylene-containing polylysine dendrimer (8-mer).1H-NMR (500 MHz, D2O, HOD = !4.65): !8.87
(s, 8H), 7.52 (m, 48H), 5.37 (s, 16H), 4.80 (brs, 8H) ,4.45 (m, 16H), 4.21 (m, 8H), 2.91-3.32 (m, 16H),
2.49 (brs, 8H), 2.43 (m, 16H), 2.01 (s, 3H x 8, Ac), 2.55 - 280 (m, 16H),1.15 1.50 (m, 32H). MALDI-
TOF-MS m/z calcd for C208H259N48O33(M+H)+3959.0, found 3959.0.
Preparation of azide derivative of bis--Neu(2-6)Gal containing N-glycan (azide a):To a solution ofbis-"-Neu(2-6)Gal containingN-glycan-Asn (provided by Otsuka Chemical Co., Ltd., 3.9 mg, 1.7 "10
-3
mmol) and Et3N (0.55 L) in DMF (100 L) was added 7-azidoheptanoic acid succinimidyl ester (1.4 mg,
5.0 "10-3mmol) and the solution was stirred at room temperature overnight under Ar atmosphere. After
the solvent was removed in vacuo, the residue was purified by HPLC [column: Nacalai Tesque 5C18-
AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-100% gradient over 40 min, 1 mL/min);
UV detection at 250 nm; retention time: 10.5 min, see Fig. SI-3 (azide awas eluted at 9.4 min at the
gradient over 20 min)]. The fraction containing the desired product was lyophilized to give the azide aas
an amorphous solid (3.9 mg, 94%). 1H-NMR (500 MHz, D2O, HOD = !4.65): !4.93 (s, 1H), 4.84 (d,J=
10 Hz, 1H), 4.79 (s, 1H), 4.76 (s, 1H), 4.62 (s, 1H), 4.56 (m, 3H), 4.40 (d,J= 8 Hz, 2H), 4.25 (brs, 1H),
4.05 (brs, 1H), 3.90 (brs, 1H), 3.26-3.83 (m, 54H), 2.61 (dd, J= 4.5 Hz, 12 Hz, 2H), 2.11 (t, J= 7 Hz,
2H), 1.93 (s, 3H x 6, Ac), 1.42 (m, 5H), 1.53 (dd,J= 12 Hz, 2H), 1.42 (m, 5H), 1.17 (m, 5H); MALDI-
TOF-MS m/zcalcd for C95H158N11O65(M+H)+2492.9, found 2492.9.
OOO
HO
O
HOHO
HO
O
O
HOO
HO
N
O
HO
HO
OOAcHN
HO
HO OH
HO
COOH
OH
O
N
HO
HO
O O
N
HO
HO
N H
N
COOH
OO
O
AcH
AcHH
AcH
N3
H
O
OHO
HO
HO
O
O
NHO
O
OHO
OH
HO
O
OOAcHN
HO
COOH
HO
OHOH
H
AcH
azidea
OOO
HO
O
HOHO
HO
O
O
HOO
HO
N
O
HO
HO
OOAcHN
HO
HO OH
HO
COOH
OH
O
N
HO
HO
O O
N
HO
HO
HN NH2
COOHO
O
AcH
AcHH
AcH
O
OHO
HO
HO
O
O
NHO
O
OHO
OH
HO
OOOAcHN
HO
COOH
HO
OHOH
H
AcH
-
8/13/2019 2010 Noninvasive SI
9/26
8
Azide derivative of asialo N-glycan (azide b):To a solution of an asialo N-glycan-Asn (1.1 mg, 6.2 "
10-4mmol) and Et3N (0.26 L) in DMF (100 L) was added 7-azidoheptanoic acid succinimidyl ester
(500 g, 1.9 " 10-3 mmol) and the mixture was stirred overnight at room temperature under Ar
atmosphere. After the solvent was removed in vacuo, the residue was purified by HPLC [column: Nacalai
Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-100% gradient over 20 min,
1 mL/min); UV detection at 250 nm; retention time: 9.5 min]. The fraction containing the desired product
was lyophilized to give the azide bas an amorphous solid (1.2 mg, 96 %). 1H-NMR (500 MHz, D2O,
HOD = !4.65): !4.92 (s, 1H), 4.83 (d,J= 10 Hz, 1H), 4.78 (s, 1H), 4.93 (s, 1H), 4.56 (s, 1H), 4.45 (m,
3H), 4.26 (d,J= 8 Hz, 2H), 4.05 (brs, 1H), 3.99 (brs, 1H), 3.90 (brs, 1H), 3.45-4.01 (m, 58H), 2.59 (dd,J
= 4.5 Hz, 12 Hz, 2H), 2.08 (t, J= 7 Hz, 2H), 1.78-1.95 (s, 3H x 6, Ac), 1.41 (m, 5H), 1.17 (m, 5H);
MALDI-TOF-MS m/zcalcd for C95H158N11O65(M+H)+1910.7, found 1910.7.
azideb
O
OHOHO
HO
OOO
HO
O
HOHO
HO
O
O
HOO
HOO
HO
HO
OH
OH
O
HO
HO
O O
HO
HO
HN
HN
COOH
OO
OH
N3
O
OHO
O
OHO
OH
HO
O
HO
H
NHAc
NHAcNHAc
AcHN
O
OHOHO
HO
OOO
HO
O
HOHO
HO
O
O
HOO
HOO
HO
HO
OH
OH
O
HO
HO
O O
HO
HO
HN NH2
COOHO
OH
O
OHO
O
OHO
OH
HO
O
HO
H
NHAc
NHAcNHAc
AcHN
-
8/13/2019 2010 Noninvasive SI
10/26
9
Azide derivative of bis--Neu(2-3)Gal containing N-glycan (azide c):To a solution of bis-"-Neu(2-
3)Gal containing N-glycan-Asn (900 g, 3.9 " 10-4
mmol) and Et3N (0.26 L) in DMF(100 L) was
added 7-azidoheptanoic acid succinimidyl ester (310 g, 1.2 " 10-3mmol) and the mixture was stirred
overnight at room temperature under Ar atmosphere. After the solvent was removed in vacuo, the residue
was purified by HPLC [column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing
0.1% TFA (10-100% gradient over 20 min, 1 mL/min); UV detection at 250 nm; retention time: 9.3 min].
The fraction containing the desired product was lyophilized to give the azide c as an amorphous solid
(820 g, 85%).1H-NMR (500 MHz, D2O, HOD = !4.65): !4.90 (s, 1H), 4.85 (d,J= 10.5 Hz, 1H), 4.80
(s, 1H), 4.40 (d,J= 7.0 Hz, 2H), 4.30 (m, 3H), 4.05 (brs, 1H), 3.97 (brs, 1H), 3.90 (brs, 2H), 3.20-3.80
(m, 54H), 2.62 (dd,J= 4.5 Hz, 12 Hz, 2H), 2.10 (m, 2H), 1.87 (s, 3H x 6, Ac), , 1.50 (dd,J= 12 Hz, 2H),
1.45 (m, 5H), 1.18 (m, 5H); MALDI-TOF-MS m/zcalcd for C95H158N11O65(M+H)+2492.9, found 2492.9.
azidecO
AcHN
HO
HOOH
HO
HOOC
OAcHN
HO
COOH
HO
OHOH
O
OHOHO
HO
OOO
HO
O
HOHO
HOO
O
HOO
HO
N
O
O
HOOH
OH
O
N
HO
HO
O O
N
HO
HO
HN
HN
COOH
OO
O
AcH
AcHH
AcH
N3
O
O
NHOO
OHO
OH
O
O OHH
AcH
OAcHN
HO
HOOH
HO
HOOC
OAcHN
HO
COOH
HO
OHOH
O
OHOHO
HO
OOO
HO
O
HOHO
HOO
O
HOO
HO
N
O
O
HOOH
OH
O
N
HO
HO
O O
N
HO
HO
HN NH2
COOHO
O
AcH
AcHH
AcH
O
O
NHOO
OHO
OH
O
O OHH
AcH
-
8/13/2019 2010 Noninvasive SI
11/26
10
Azide derivative of mixed -Neu(2-3)Gal & -Neu(2-6)Gal containing N-glycan (azide d): To a
solution of "-Neu(2-3)Gal & "-Neu(2-6)Gal containing N-glycan-Asn (1.0 mg, 4.3 " 10-4mmol) and
Et3N (0.26 L) in DMF (100 L) was added 7-azidoheptanoic acid succinimidyl ester (340 g, 1.3 "10-3
mmol) and the mixture was stirred overnight at room temperature under Ar atmosphere. After the solvent
was removed in vacuo, the residue was purified by HPLC [column: Nacalai Tesque 5C18-AR300, 4.6 x
250 mm; MeCN in H2O containing 0.1% TFA (10-100% gradient over 20 min, 1 mL/min); UV detection
at 250 nm; retention time: 9.4 min]. The fraction containing the desired product was lyophilized to give
the azide das an amorphous solid (940 g, 88%).1H-NMR (500 MHz, D2O, HOD = !4.65): !4.97 (s,
1H), 4.93 (d,J= 9.5 Hz, 1H), 4.81 (s, 1H), 4.71 (s, 1H), 4.60 (s, 1H), 4.50 (m, 3H), 4.37 (d,J= 8 Hz, 2H),
4.17 (brs, 1H), 4.11 (brs, 1H), 4.04 (brs, 2H), 3.38 3.92 (m, 54H), 2.82 (dd, J= 5 Hz, 12 Hz, 2H), 2.67
(dd,J= 4.5 Hz, 12Hz, 1H), 2.59 (dd,J= 4.5 Hz, 12Hz, 1H), 2.11 (m, 2H), 1.90-2.02 (s, 3H x 6, Ac), 1.73
(dd, J= 12 Hz, 1H), 1.63 (dd, J= 12 Hz, 1H), 1.42 (m, 5H), 1.20 (m, 5H); MALDI-TOF-MS m/zcalcd
for C95H158N11O65(M+H)+2492.9, found 2493.0.
azided
OAcHN
HO
COOH
HO
OHOH
OOO
HO
O
HOHO
HO
O
O
HOO
HO
N
O
HO
HO
OO
AcHN
HO
HO OH
HO
COOH
OH
O
N
HO
HO
O O
N
HO
HO
HN
HN
COOH
OO
O
AcH
AcHH
AcH
N3
O
OHO
HO
HO
O
O
NHO
O
OHO
OH
O
OH OH
AcHOAcHN
HO
COOH
HO
OHOH
OOO
HO
O
HOHO
HO
O
O
HOO
HO
N
O
HO
HO
OOAcHN
HO
HO OH
HO
COOH
OH
O
N
HO
HO
O O
N
HO
HO
HN NH2
COOHO
O
AcH
AcHH
AcH
O
OHO
HO
HO
O
O
NHO
O
OHO
OH
O
OH OH
AcH
Azide derivative of mixed -Neu(2-6)Gal & -Neu(2-3)Gal containing N-glycan (azide e): To a
solution of "-Neu(2-6)Gal & "-Neu(2-3)Gal containing N-glycan-Asn (1.0 mg, 4.3 " 10-4 mmol) and
Et3N (0.26 L) in DMF (100 L) was added 7-azidoheptanoic acid succinimidyl ester (340 g, 1.3 "10-3
mmol) and the mixture was stirred overnight at room temperature under Ar atmosphere. After the solvent
was removed in vacuo, the residue was purified by HPLC [column: Nacalai Tesque 5C18-AR300, 4.6 x
250 mm; MeCN in H2O containing 0.1% TFA (10-100% gradient over 20 min, 1 mL/min); UV detection
at 250 nm; retention time: 9.4 min]. The fraction containing the desired product was lyophilized to give
the azide eas an amorphous solid (900 g, 84%).1H-NMR (500 MHz, D2O, HOD = !4.65): !4.98 (s,
1H), 4.92 (d,J= 9.5 Hz, 1H), 4.77 (s, 1H), 4.70 (s, 1H), 4.58 (s, 1H), 4.45 (m, 3H), 4.30 (d, J= 7.5 Hz,
2H), 4.10 (brs, 1H), 4.04 (brs, 1H), 3.97 (brs, 2H), 3.30-3.92 (m, 54H), 2.75 (dd, J= 4.5 Hz, 12 Hz, 2H),
2.60 (dd, J= 4 Hz, 12Hz, 1H), 2.50 (dd, J= 4 Hz, 12Hz, 1H), 2.05 (m, 2H), 1.82-1.95 (s, 3H x 6, Ac),
1.65 (dd, J= 12 Hz, 1H), 1.56 (dd, J= 12 Hz, 1H), 1.39 (m, 5H), 1.17 (m, 5H); MALDI-TOF-MS m/z
calcd for C95H158N11O65(M+H)+2492.9, found 2492.0.
-
8/13/2019 2010 Noninvasive SI
12/26
11
azideeO
AcHN
HO
HOOH
HO
HOOC
O
OHOHO
HO
OOO
HO
O
HO
HOHO
O
O
HOO
HO
N
O
O
HO OH
OH
O
N
HO
HO
O O
N
HO
HO
HN
HN
COOH
OO
O
AcH
AcHH
AcH
N3
O
O
NHO
O
OHO
OH
HO
O
OOAcHN
HO
COOH
HO
OHOH
H
AcH
OAcHN
HO
HOOH
HO
HOOC
O
OHOHO
HO
OOO
HO
OHOHO
HO
O
O
HOO
HO
N
O
O
HO OH
OH
O
N
HO
HO
O O
N
HO
HO
HN NH2
COOHO
O
AcH
AcHH
AcH
O
O
NHO
O
OHO
OH
HO
O
OOAcHN
HO
COOH
HO
OHOH
H
AcH
-
8/13/2019 2010 Noninvasive SI
13/26
12
Preparation of glycocluster 3a. CuSO4(64 g, 3.2 x 10-4 mmol), sodium L-ascorbate (238 g, 1.2 x 10
-3
mmol), and diisopropylethylamine (74 nL) were added to a solution of acetylene-containing polylysine
dendrimer (16-mer, 158 g, 2.0 x 10-5 mmol) andN-glycan azide a(1.0 mg, 4.0 x 10
-4 mmol) in DMF (50
L) and H2O (50 L) at room temperature under Ar atmosphere. After the mixture was stirred for 40 min
at this temperature, DOTA (1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid, 647 g, 1.56 x 10-3
mmol) was added, and the resulting solution was stirred for another 40 min. Low-molecule weight
compounds were filtered using the Microcon (centrifugal filter YM-10, 10,000 cut, Millipore), and the
resulting aqueous solution was lipophilized to give glycocluster 3aas amorphous solid (960 g, quant).
The purity of the product was evaluated by reverse phase HPLC [column: Nacalai Tesque 5C18-AR300,
4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-100% gradient over 40 min, 1 mL/min); UV
detection at 250 nm; retention time of 3a: 12.4 min, see Fig. SI-3]. Molecular weight was evaluated by
MALDI-TOF-MS (Fig. SI-6) and size-partitioning gel filtration analysis as shown in Fig. SI-5 (column:
TSK-Gel G4000PWXL, 7.8 x 300 mm; 0.1 M NaCl at pH 7.2, 1 mL/min; retention time: 9.0 min):1H-
NMR (500 MHz, D2O)!8.71 (brs, 1H x 16, His-aromatic protons), 7.67 (s, 1H x 16, triazole proton),
7.12-7.37 (m, 6H x 16, Bn- and His-aromatic protons), 5.26 (brs, 2H x 16, benzylic protons of Bn), 5.10
(s, 1H x 16), 5.02 (s, 1H x 16), 4.95 (s, 1H x 16), 4.56 (m, 2H x 16), 4.43 (m, 3H x 16), 4.22 (s, 1H x 16),
4.17 (s, 1H x 16), 4.09 (s, 1H x 16), 4.20-4.30 (m, "-protons of Lys), 3.44-3.98 (m, characteristic vicinal
protons of sugar hydroxyls), 2.86-3.23 (m, #-protons on His), 2.74-2.82 (m, #-protons of Asn), 2.62-2.67
(m, H-3eqNeu
), 2.24-2.28 (m, #-protons of triazolic Ala), 1.92-2.06 (multiple s, Ac), 1.70 (dd, J = 12Hz,
12Hz, H-3axNeu), 1.54-1.60 and 1.30-1.33 (m, part of acylpentane-linker protons), 1.82-1.91, 1.65-1.79,
1.39-1.48, 1.26-1.38, and 0.82-1.24 (m, $- and !-protons of Lys).
-
8/13/2019 2010 Noninvasive SI
14/26
13
Figure SI-3. Reverse phase HPLC of acetylene-containing polylysine dendrimer (16-mer), N-glycan
azide a, click reaction mixture, and purified glycocluster 3aafter Microcon filtration [column: Nacalai
Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-100% gradient over 40 min,
1 mL/min); UV detection at 250 nm].
Figure SI-4.1H-NMR of 3a(500 MHz, D2O).
-
8/13/2019 2010 Noninvasive SI
15/26
14
Glycocluster 1a. CuSO4 (51 g, 3.2 x 10-4 mmol), sodium L-ascorbate (192 g, 9.6 x 10
-3 mmol), and
diisopropylethylamine (60 nL) were added to a solution of acetylene-containing polylysine dendrimer (4-
mer, 160 g, 8.0 x 10-5 mmol) andN-glycan azide a(800 g, 3.2 x 10
-4 mmol) in DMF (50 L) and H2O
(50 L) at room temperature under Ar atmosphere. After the mixture was stirred for 40 min at this
temperature, DOTA (520 g, 1.2 x 10-3 mmol) was added, and the resulting solution was stirred for
another 40 min. Low-molecule weight compounds were filtered using the Microcon (centrifugal filter
YM-10, 10,000 cut, Millipore), and the resulting aqueous solution was lipophilized to give glycocluster
1aas amorphous solid (760 g, quant). The purity of the product was evaluated by reverse phase HPLC
[column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-100%
gradient over 40 min, 1 mL/min); UV detection at 250 nm; retention time: 12.2 min]. Molecular weight
was evaluated by gel filtration analysis as shown in Fig. SI-5 (column: TSK-Gel G4000PW XL, 7.8 x 300
mm; 0.1 M NaCl at pH 7.2, 1 mL/min; retention time: 11.9 min): 1H-NMR (500 MHz, D2O, HOD = !
4.65)!8.74 (brs, 1H x 4, His-aromatic protons), 7.65 (s, 1H x 4, triazole protons), 7.15-7.50 (m, 6H x 4,
Bn- and His-aromatic protons), 5.29 (brs, 2H x 4, benzylic protons of Bn), 5.09 (s, 1H x 4), 5.02 (brs, 1H
x 4), 4.96 (s, 1H x 4), 4.56 (s, 1H x 4), 4.45 (m, 2H x 4), 4.22 (m, 3H x 4), 4.17 (s, 1H x 4), 4.09 (s, 1H x
4), 4.10-4.30 (m, "-protons of Lys), 3.40-4.02 (m, characteristic vicinal protons of sugar hydroxyls), 2.89-
3.25 (m, #-protons on His), 2.75-2.85 (m, #-protons of Asn), 2.60-2.65 (m, H-3eqNeu), 2.26-2.30 (m, #-
protons of triazolic Ala), 1.92-2.05 (multiple s, Ac), 1.68 (dd,J = 12Hz, 12Hz, H-3axNeu
), 1.54-1.59 and
1.30-1.35 (m, part of acylpentane-linker protons), 1.80-1.91, 1.65-1.79, 1.36-1.48, 1.22-1.38, and 0.85-
1.20 (m, $- and !-protons of Lys).
Glycocluster 2a. CuSO4 (50 g, 3.2 x 10-4 mmol), sodium L-ascorbate (186 g, 9.4 x 10
-4 mmol), and
diisopropylethylamine (72 nL, 416 nmol) were added to a solution of acetylene-containing polylysine
dendrimer (8-mer, 155 g, 3.9 x 10-5 mmol) andN-glycan azide a(980 g, 3.9 x 10
-4 mmol) in DMF (50
L) and H2O (50 L) at room temperature under Ar atmosphere. After the mixture was stirred for 40 min
at this temperature, DOTA (630 g, 1.56 x 10-3
mmol) was added, and the resulting solution was stirred
for another 40 min. Low-molecule weight compounds were filtered using the Microcon (centrifugal
filter YM-10, 10,000 cut, Millipore), and the resulting aqueous solution was lipophilized to give
glycocluster 2aas amorphous solid (970 g, quant). The purity of the product was evaluated by reverse
phase HPLC [column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA
(10-100% gradient over 40 min, 1 mL/min); UV detection at 250 nm; retention time of 2a: 12.2 min].
Molecular weight was evaluated by gel filtration analysis as shown in Fig. SI-5 (column: TSK-Gel
G4000PWXL, 7.8 x 300 mm; 0.1 M NaCl at pH 7.2, 1 mL/min; retention time: 10.6 min):1
H-NMR (500MHz, D2O, HOD = !4.65)!8.70 (brs, 1H x 8, His-aromatic protons), 7.63 (s, 1H x 8, triazole protons),
-
8/13/2019 2010 Noninvasive SI
16/26
15
7.16-7.48 (m, 6H x 8, Bn- and His-aromatic protons), 5.28 (brs, 2H x 8, benzylic protons of Bn), 5.1 (s,
1H x 8), 5.02 (brs, 1H x 8), 4.95 (s, 1H x 8), 4.56 (s, 1H x 8), 4.43 (m, 2H x 8, 4.23 (m, 3H x 8), 4.15 (s,
1H x 8), 4.10 (s, 1H x 8), 4.08-4.31 (m, "-protons of Lys), 3.39-4.03 (m, characteristic vicinal protons of
sugar hydroxyls), 2.88-3.20 (m, #-protons on His), 2.73-2.80 (m, #-protons of Asn), 2.59-2.67 (m, H-
3eqNeu), 2.28-2.36 (m, #-protons of triazolic Ala), 1.90-2.03 (multiple s, Ac), 1.70 (dd, J = 12Hz, 12Hz,
H-3axNeu), 1.50-1.60 and 1.32-1.38 (m, part of acylpentane linker protons), 1.76-1.91, 1.62-1.75, 1.34-
1.48, 1.25-1.32, and 0.87-1.23 (m, $- and !-protons of Lys).
Glycocluster 3b. CuSO4(120 g, 6.7 x 10-4 mmol), sodium L-ascorbate (400 g, 2.0 x 10
-3 mmol), and
diisopropylethylamine (120 nL, 690 nmol) were added to a solution of acetylene-containing polylysine
dendrimer (16-mer, 331 g, 4.2 x 10-5 mmol) andN-glycan azide b(1.6 mg, 8.4 x 10
-4 mmol) in DMF (50
L) and H2O (50 L) at room temperature under Ar atmosphere. After the mixture was stirred for 40 min
at this temperature, DOTA (1.4 mg, 3.38 x 10-3
mmol) was added, and the resulting solution was stirred
for another 40 min. Low-molecule weight compounds were filtered using the Microcon (centrifugal
filter YM-10, 10,000 cut, Millipore), and the resulting aqueous solution was lipophilized to give
glycocluster 3bas amorphous solid (1.68 mg, quant). The purity of the product was evaluated by reverse
phase HPLC [column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA
(10-100% gradient over 40 min, 1 mL/min); UV detection at 250 nm; retention time: 12.6 min].
Molecular weight was evaluated by MALDI-TOF-MS (Fig. SI-6) and gel filtration analysis as shown inFig. SI-5 (column: TSK-Gel G4000PWXL, 7.8 x 300 mm; 0.1 M NaCl at pH 7.2, 1 mL/min; retention
time: 9.9 min): 1H-NMR (500 MHz, D2O, HOD = !4.65)!8.69 (brs, 1H x 16, His-aromatic protons),
7.64 (s, 1H x 16, triazole proton), 7.10-7.36 (m, 6H x 16, Bn- and His-aromatic protons), 5.26 (brs, 2H x
16, benzylic protons of Bn), 5.01 (s, 1H x 16), 4.91 (brs, 1H x 16), 4.86 (s, 1H x 16), 4.60 (s, 1H x 16),
4.50 (m, 2H x 16), 4.40 (m, 3H x 16), 4.27 (s, 1H x 16), 4.19 (s, 1H x 16), 4.10 (s, 1H x 16), 3.44-3.98 (m,
including characteristic vicinal protons of sugar hydroxyls and "-protons of Lys), 2.85-3.10 (m, #-protons
on His), 2.70-2.80 (m, #-protons of Asn), 2.30-2.35 (m, #-protons of triazolic Ala), 1.98-2.12 (multiple s,Ac), 1.45-1.55 and 1.15-1.26 (m, part of acylpentane linker protons), 1.80-1.90, 1.60-1.78, 1.40-1.55,
1.26-1.36 and 0.90-1.23 (m, $- and !-protons of Lys).
Glycocluster 3c. CuSO4 (42 g, 2.6 x 10-4
mmol), sodium L-ascorbate (156 g, 7.9 x 10-4
mmol), and
diisopropylethylamine (60 nL) were added to a solution of acetylene-containing polylysine dendrimer
(16-mer, 129 g, 1.64 x 10-5 mmol) andN-glycan azide c(820 g, 3.29 x 10-4 mmol) in DMF (50 L) and
H2O (50 L) at room temperature under Ar atmosphere. After the mixture was stirred for 40 min at this
temperature, DOTA (532 g, 1.3 x 10-3 mmol) was added, and the resulting solution was stirred for
-
8/13/2019 2010 Noninvasive SI
17/26
16
another 40 min. Low-molecule weight compounds were filtered using the Microcon (centrifugal filter
YM-10, 10,000 cut, Millipore), and the resulting aqueous solution was lipophilized to give glycocluster
3cas amorphous solid (780 g, quant). The purity of the product was evaluated by reverse phase HPLC
[column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-100%
gradient over 40 min, 1 mL/min); UV detection at 250 nm; retention time: 12.1 min]. Molecular weight
was evaluated by gel filtration analysis (column: TSK-Gel G4000PWXL, 7.8 x 300 mm; 0.1 M NaCl at pH
7.2, 1 mL/min; retention time: 9.0 min):1H-NMR (500 MHz, D2O, HOD = !4.65)!8.73 (brs, 1H x 16,
His-aromatic protons), 7.65 (s, 1H x 16, triazole proton), 7.10-7.40 (m, 6H x 16, Bn- and His-aromatic
protons), 5.23 (brs, 2H x 16, benzylic protons of Bn), 4.99 (s, 1H x 16), 4.92 (brs, 1H x 16), 4.86 (s, 1H x
16), 4.57 (s, 1H x 16), 4.45 (m, 1H x 16), 4.37 (m, 2H x 16), 4.15 (brs, 1H x 16), 4.05 (brs, 1H x 16), 3.99
(brs, 2H x 16), 3.25-3.96 (m, characteristic vicinal protons of sugar hydroxyls and "-protons of Lys),
2.80-2.95 (m, #-protons on His), 2.55-2.75 (m, #-protons of Asn), 2.45-2.53 (m, H-3eqNeu
), 2.35-2.45 (m,
#-protons of triazolic Ala), 1.80-2.00 (multiple s, Ac), 1.55 (dd,J = 12Hz, 12Hz, H-3axNeu
), 1.60-1.75 and
1.12-1.25 (m, part of acylpentane linker protons), 1.75-1.83, 1.60-1.78, 1.26-1.36 and 0.90-1.25 (m, $-
and !-protons of Lys).
Glycocluster 3d. CuSO4 (48 g, 3.01 x 10-4 mmol), sodium L-ascorbate (179 g, 1.2 x 10
-3 mmol), and
diisopropylethylamine (60 nL) were added to a solution of acetylene-containing polylysine dendrimer
(16-mer, 148 g, 1.9 x 10-5
mmol) andN-glycan azide d(940 g, 3.8 x 10-4
mmol) in DMF (50 L) andH2O (50 L) at room temperature under Ar atmosphere. After the mixture was stirred for 40 min at this
temperature, DOTA (610 g, 1.51 x 10-3 mmol) was added, and the resulting solution was stirred for
another 40 min. Low-molecule weight compounds were filtered using the Microcon (centrifugal filter
YM-10, 10,000 cut, Millipore), and the resulting aqueous solution was lipophilized to give glycocluster
3d as an amorphous solid (900 g, quant). The purity of the product was evaluated by reverse phase
HPLC [column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-
100% gradient over 40 min, 1 mL/min); UV detection at 250 nm; retention time: 12.6 min]. Molecularweight was evaluated by gel filtration analysis (column: TSK-Gel G4000PWXL, 7.8 x 300 mm; 0.1 M
NaCl at pH 7.2, 1 mL/min; retention time: 9.0 min):1H-NMR (500 MHz, D2O, HOD = !4.65)!8.70 (brs,
1H x 16, His-aromatic protons), 7.66 (s, 1H x 16, triazole proton), 7.14-7.38 (m, 6H x 16, Bn- and His-
aromatic protons), 5.25 (brs, 2H x 16, benzylic protons of Bn), 5.05 (s, 1H x 16), 4.95 (brs, 1H x 16), 4.79
(s, 1H x 16), 4.50 (m, 2H x 16), 4.42 (m, 3H x 16), 4.10 (s, 1H x 16), 4.03 (s, 1H x 16), 3.95 (s, 1H x 16),
3.95-4.13 (m, "-protons of Lys), 3.26-3.90 (m, characteristic vicinal protons of sugar hydroxyls), 2.70-
3.00 (m, #-protons on His), 2.56-2.70 (m, #-protons of Asn), 2.45-2.49 and 2.50-2.55 (m, H-3eq
Neu
), 2.00-2.10 (m, #-protons of triazolic Ala), 1.80-1.98 (multiple s, Ac), 1.55 and 1.65 (m, H-3ax
Neu), 1.55-1.70
-
8/13/2019 2010 Noninvasive SI
18/26
17
and 1.20-1.35 (m, part of acylpentane linker protons), 1.60-1.78, 1.40-1.55, 1.26-1.36 and 0.87-1.20 (m,
$- and !-protons of Lys).
Glycocluster 3e. CuSO4 (46 g, 2.9 x 10-4 mmol), sodium L-ascorbate (172 g, 8.7 x 10
-4 mmol), and
diisopropylethylamine (50 nL) were added to a solution of acetylene-containing polylysine dendrimer
(16-mer, 142 g, 1.8 x 10-5 mmol) andN-glycan azide e(900 g, 3.6 x 10
-4 mmol) in DMF (50 L) and
H2O (50 L) at room temperature under Ar atmosphere. After the mixture was stirred for 40 min at this
temperature, DOTA (584 g, 1.44 x 10-3
mmol) was added, and the resulting solution was stirred for
another 40 min. Low-molecule weight compounds were filtered using the Microcon (centrifugal filter
YM-10, 10,000 cut, Millipore), and the resulting aqueous solution was lipophilized to give glycocluster
3eas amorphous solid (900 g, quant). The purity of the product was evaluated by reverse phase HPLC
[column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O containing 0.1% TFA (10-100%
gradient over 40 min, 1 mL/min); UV detection at 250 nm; retention time: 12.3 min]. Molecular weight
was evaluated by gel filtration analysis (column: TSK-Gel G4000PWXL, 7.8 x 300 mm; 0.1 M NaCl at pH
7.2, 1 mL/min; retention time: 9.0 min):1H-NMR (500 MHz, D2O, HOD = !4.65)!8.69 (brs, 1H x 16,
His-aromatic protons), 7.60 (s, 1H x 16, triazole proton), 7.05-7.25 (m, 6H x 16, Bn- and His-aromatic
protons), 5.18 (brs, 2H x 16, benzylic protons of Bn), 4.98 (s, 1H x 16), 4.90 (brs, 1H x 16), 4.78 (s, 1H x
16), 4.56 (m, 2H x 16), 4.30 (m, 3H x 16), 4.09 (s, 1H x 16), 4.02 (s, 1H x 16), 3.96 (s, 1H x 16), 4.10-
4.20 (m, "-protons of Lys), 3.30-3.85 (m, characteristic vicinal protons of sugar hydroxyls), 2.73-2.93 (m,
#-protons on His), 2.56-2.69 (m, #-protons of Asn), 2.56-2.62 and 2.63-2.70 (m, H-3eqNeu), 1.98-2.18 (m,
#-protons of triazolic Ala), 1.80-1.95 (multiple s, Ac), 1.60 and 1.67 (m, H-3 axNeu
), 1.40-1.55 and 1.25-
1.36 (m, part of acylpentane linker protons), 1.69-1.78, 1.40-1.55, 1.06-1.15 and 0.90-1.05 (m, $- and !-
protons of Lys).
-
8/13/2019 2010 Noninvasive SI
19/26
18
Figure SI-5. Molecular weight analysis of glycoclusters 1a, 2a, 3a, and 3b, based on size-partitioning
gel-filtration (column: TSK-Gel G4000PWXL, 7.8 x 300 mm; eluent: 0.1 M NaCl, pH 7.2 at rt; flow rate:
1 mL/min; UV detection at 215 nm). Human serum albumin (HSA, 66 kDa), orosomucoid (44 kDa), and
acetylene-containing polylysine dendrimer (8 kDa) were used as standards. While bis-sialylated clusters
3aand 3c-3eshowed same retention time at 9.0 min, smaller asialo-derivative was eluted at 9.9 min (see
each glycocluster data).
-
8/13/2019 2010 Noninvasive SI
20/26
19
Figure SI-6. MALDI-TOF-MS analysis of glycocluster 3aand 3b. Sinapinic acid containing 0.1% TFA
was used as the matrix.
-
8/13/2019 2010 Noninvasive SI
21/26
20
Representative procedures for labeling of glycoclusters. DOTA & fluorescence-labeling was
performed by the previously reported procedure.[8]
Thus, to a solution of glycocluster 3a (210 g, 4.5
nmol) in distilled water (50 L) was added a solution of DOTA-conjugated aldehyde (see Scheme 1)[8]
(62 g, 90 nmol) in water (20 L) at room temperature. After the mixture was stirred at room temperature
for 30 min, the excess reagent was filtered off by using the Microcon (centrifugal filter YM-10, 10,000
cut, Millipore), and the resulting DOTA-glycocluster 3a dissolved in 1 M HEPES buffer was directly
used for the radiometal labeling.
Labeling of DOTA-glycocluster with68
Ga. A TiO2-based, commercially available68Ge/68Ga generator
(10 mCi, Eckert & Ziegler Eurotope, Berlin, Germany) was eluted with 1 N HCl, and 68Ga was purified
by a cation exchange column (AG 50W-X8 resin, 400 Mesh, Bio-Rad Laboratories, Inc., Hercules, CA,
USA). After 68GaCl3was eluted with 3.0 mL of 98% acetone-0.05 M HCl solution, acetone was removed
under a nitrogen stream. DOTA-glycocluster obtained above (4.5 nmol) in 1 M HEPES buffer (400 L)
was added to the eluent, and the pH of this solution was adjusted to 3.5 by adding 1 M HEPES buffer.
After the mixture was incubated at 95 C for 15 min, the resulting [68
Ga]DOTA-glycocluster was isolated
by reverse phase HPLC [Fig. SI-7, column: Nacalai Tesque 5C18-AR300, 4.6 x 250 mm; MeCN in H2O
containing 0.1% TFA (10-100% gradient over 10 min, 1 mL/min); detection by UV at 250 nm and RI;
retention time at 8 min for 3a]. The eluent was evaporated under reduced pressure and the residue was
dissolved in 0.1M PBS buffer (pH=7.4) for PET study. Only 500 pmol of the glycocluster was used for
PET imaging.
Figure SI-7. HPLC purification of [68Ga]DOTA glycocluster 3a(RI detection).
-
8/13/2019 2010 Noninvasive SI
22/26
21
General procedure of [68
Ga]PET imaging. The animal studies were performed according to a protocol
approved by the Ethics Committee of RIKEN. Briefly, the PET study was conducted on male BALB/c
nude mouse weighing 23-27 g at 9-12 weeks of age (Japan SLC, Inc., Hamamatsu, Japan) under
inhalation anesthesia with isoflurane (Escain, Mylan, Osaka, Japan), and was used a small animal PET
scanner, the microPET Focus 220 (Siemens Medical Solutions Inc., Knoxville, TN, USA). The mice were
continuously anesthetized with isoflurane during the experiment. [68Ga]DOTA-glycocluster conjugates
(500 pmol) at a dose of 6.9-12.9 MBq in 100 L were injected via a tail vein, and then the emission data
was collected for 240 min postinjection. Three dimensional dynamic images were reconstructed by
filtered back projection method or ordered subset expectation maximization (OSEM) algorithm with
attenuation correction. In order to analyze the tracer disposition kinetics, another four images were
reconstructed from the summation data of 0 to 5 min, 30 to 60 min, 90 to 120 min, and 210 to 240 min
after injection of [68
Ga]DOTA-glycoclusters. Quantitative analysis was performed using ASIPro VM
version 6.6.2.0 software (Siemens Medical Solutions Inc., Knoxville, TN, USA). Regions of interest
(ROIs) were placed on the tissue region.
Figure SI-8. Standardized uptake value (SUV) of68
Ga-DOTA-Labeled glycoclusters 1a,2a,and3a-cin
normal BALB/c nude mice. SUV was normalized by radioactivity in the tissue region, injected dose, and
weight of the subjects. These values represent the means and S.Ds.
General procedure of fluorescence imaging. Eight week-old mice (BALB/cAJclnu/nu, CLEA Japan,
Inc.) was used for in vivo fluorescence imaging. The cancer model was prepared by subcutaneouslyinjecting the DLD-1 (107 cells / 100 L) to the dorsal division of mouse (BALB/cAJclnu/nu, CLEA
-
8/13/2019 2010 Noninvasive SI
23/26
22
Japan, Inc.). The cancer had grew up to proper size for imaging purposes, after 2~3 weeks from the
injection, and therefore, nine week-old (2 weeks later from injection of DLD-1) was used for imaging.
Cy5-labeled glycoclusters (500 pmol / 100 L in physiological salt solution) were injected from the
caudal vein without anesthesia, and whole body scanning was performed by using eXplore Optix, GE
Healthcare, Bioscience (excitation at 646 nm, emission 663 nm), 45, 60, 120, 180, and 240 min after
injection. Fluorescence images were collected under inhalation anesthesia with Isoflurane; the
concentration of Isoflurane was 4% from 15 min to 60 min after the injection, and then kept at 1.5-2%
during the rest of the measurements.
Figure SI-9.(a)-(e): Dynamic fluorescence imaging of glycoclusters 3a-ein DLD-1 implanted nude mice
(left femoral region) as a cancer model; (a) glycocluster 3b; (b) glycocluster 3c; (c) glycocluster 3a; (d)
glycocluster 3d; (e) glycocluster 3e. Cy5-Labeled glycoclusters 3a-ewere administered from the tail vein
of the mice (n=3, 500 pmol, 100 L/mouse) and whole body scans were performed from the front side by
eXplore Optix, GE Healthcare, Bioscience (excitation at 646 nm, emission 663 nm), 4 h after injection.
Data was normalized. H: heart; L: liver; B: urinary bladder.
-
8/13/2019 2010 Noninvasive SI
24/26
23
Interaction of glycoclusters 3a-3e with B-cell lines.
-
8/13/2019 2010 Noninvasive SI
25/26
24
-
8/13/2019 2010 Noninvasive SI
26/26
25